Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
Anuh Pharma Limited engages in the manufacture and sale of bulk drugs and chemicals in India. It offers active pharmaceutical ingredients, including macrolides, anti-TB, anti-bacterial, anti-asthmatics, anti-diabetics, intermediates, expectorant, quinolones, anti-malarial, anti-gout, anti-biotic, anti-platelet, and antihistamines; and corticosteroids, including anti-inflammatory, immunosuppressant, anti-pruritic, anti-mitotic. The company also develops products, such as coagulants, gastrointestinal, anti convulsants, and cholesterol drugs. It also exports its products. The company was incorporated in 1960 and is headquartered in Mumbai, India.
Key Metrics
as of Sep 2026
Market Cap 813 Cr
P/E 18.40
Div Yield 1.85 %
Book Value โน35.10
52w High โน93.00
52w Low โน66.70
Face Value โน5.00
Quarterly Results
Rs. Crores ยท hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
194.00
202.00
197.00
186.00
186.00
198.00
160.00
166.00
138.00
164.00
172.00
150.00
161.00
Expenses
178.00
182.00
178.00
174.00
176.00
179.00
145.00
149.00
127.00
145.00
148.00
132.00
148.00
Operating Profit
16.00
20.00
19.00
12.00
10.00
19.00
15.00
17.00
11.00
19.00
24.00
18.00
14.00
OPM %
8.00
10.00
10.00
6.00
6.00
9.00
9.00
10.00
8.00
12.00
14.00
12.00
9.00
Other Income
3.00
-1.00
2.00
1.00
3.00
1.00
1.00
3.00
4.00
3.00
4.00
2.00
3.00
Depreciation
2.00
3.00
3.00
3.00
3.00
3.00
2.00
2.00
2.00
2.00
2.00
2.00
2.00
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit before tax
17.00
16.00
18.00
10.00
11.00
17.00
13.00
18.00
12.00
20.00
25.00
18.00
15.00
Tax %
32.00
25.00
25.00
23.00
24.00
28.00
22.00
17.00
22.00
22.00
24.00
23.00
24.00
Net Profit
11.00
12.00
13.00
8.00
8.00
12.00
10.00
15.00
10.00
15.00
19.00
14.00
12.00
EPS in Rs
1.14
1.17
1.34
0.76
0.83
1.24
1.03
1.50
0.95
1.53
1.91
1.38
1.17
Profit & Loss
Annual ยท Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
772.00 662.00 647.00 527.00 487.00 432.00 307.00 321.00 238.00 206.00 326.00 284.00
Expenses
709.00 600.00 571.00 476.00 439.00 387.00 284.00 291.00 220.00 183.00 289.00 253.00
Operating Profit
62.00 62.00 76.00 52.00 47.00 45.00 23.00 30.00 18.00 23.00 38.00 31.00
OPM %
8.00 9.00 12.00 10.00 10.00 10.00 8.00 9.00 8.00 11.00 12.00 11.00
Other Income
4.00 9.00 12.00 6.00 5.00 11.00 4.00 5.00 7.00 8.00 4.00 5.00
Interest
1.00 1.00 1.00 1.00 2.00 2.00 1.00 1.00 0.00 1.00 1.00 1.00
Depreciation
11.00 9.00 9.00 10.00 12.00 15.00 7.00 2.00 2.00 2.00 2.00 3.00
Profit before tax
54.00 61.00 78.00 47.00 39.00 39.00 19.00 32.00 23.00 28.00 38.00 32.00
Tax %
24.00 22.00 23.00 24.00 22.00 26.00 25.00 28.00 29.00 27.00 32.00 31.00
Net Profit
41.00 47.00 60.00 36.00 31.00 28.00 14.00 23.00 17.00 20.00 26.00 22.00
EPS in Rs
4.10 4.73 5.99 3.61 3.05 2.84 1.43 2.33 1.65 2.00 2.57 2.19
Dividend Payout %
37.00 16.00 21.00 28.00 29.00 26.00 48.00 29.00 42.00 31.00 24.00 27.00
Balance Sheet
Annual ยท Rs. Crores โ latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
50.00 25.00 25.00 25.00 25.00 25.00 13.00 13.00 13.00 13.00 13.00 4.00
Reserves
302.00 301.00 266.00 216.00 189.00 166.00 150.00 152.00 137.00 128.00 107.00 97.00
Borrowings
0.00 11.00 3.00 1.00 4.00 14.00 45.00 4.00 2.00 0.00 2.00 0.00
Other Liabilities
205.00 170.00 152.00 163.00 129.00 128.00 119.00 71.00 57.00 48.00 71.00 67.00
Total Liabilities
557.00 507.00 446.00 405.00 347.00 333.00 326.00 240.00 209.00 189.00 193.00 168.00
Fixed Assets
57.00 58.00 49.00 53.00 61.00 71.00 84.00 21.00 17.00 17.00 18.00 9.00
CWIP
0.00 0.00 0.00 0.00 0.00 0.00 0.00 34.00 6.00 0.00 0.00 0.00
Investments
84.00 106.00 97.00 91.00 43.00 31.00 80.00 39.00 66.00 70.00 43.00 43.00
Other Assets
416.00 342.00 300.00 261.00 243.00 230.00 163.00 147.00 120.00 101.00 131.00 116.00
Total Assets
557.00 507.00 446.00 405.00 347.00 333.00 326.00 240.00 209.00 189.00 193.00 168.00
Cash Flows
Annual ยท Rs. Crores โ latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Cash from Operating Activity
-3.00 37.00 13.00 54.00 29.00 -19.00 49.00 7.00 2.00 26.00 16.00 19.00
Cash from Investing Activity
18.00 -20.00 1.00 -43.00 -8.00 52.00 -77.00 3.00 2.00 -20.00 -5.00 -12.00
Cash from Financing Activity
-26.00 -5.00 -9.00 -12.00 -19.00 -33.00 22.00 -7.00 -5.00 -4.00 -9.00 -8.00
Net Cash Flow
-12.00 12.00 5.00 -2.00 2.00 0.00 -5.00 3.00 -1.00 2.00 2.00 -1.00
Free Cash Flow
-11.00 17.00 8.00 52.00 27.00 -25.00 13.00 -22.00 -5.00 25.00 6.00 18.00
CFO/OP %
16.00 78.00 42.00 130.00 80.00 -20.00 232.00 56.00 49.00 149.00 78.00 96.00
Ratios
Annual ยท Days / % โ latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
113.00 119.00 107.00 118.00 102.00 90.00 96.00 85.00 109.00 100.00 84.00 88.00
Inventory Days
90.00 54.00 57.00 66.00 77.00 90.00 98.00 64.00 64.00 72.00 35.00 27.00
Days Payable
114.00 115.00 105.00 139.00 117.00 133.00 166.00 89.00 105.00 102.00 77.00 79.00
Cash Conversion Cycle
89.00 59.00 58.00 46.00 62.00 48.00 28.00 61.00 68.00 70.00 42.00 36.00
Working Capital Days
92.00 68.00 69.00 61.00 68.00 57.00 -10.00 65.00 80.00 79.00 48.00 43.00
ROCE %
15.00 17.00 26.00 19.00 18.00 16.00 10.00 19.00 14.00 19.00 35.00 33.00
Shareholding Pattern
% holding โ latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
71.79
71.79
71.81
71.81
69.91
69.91
69.91
69.91
69.91
69.91
69.94
70.59
FIIs
0.01
0.05
0.00
0.00
0.04
0.04
0.02
0.02
0.03
0.03
0.00
0.00
DIIs
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.10
0.00
0.00
Public
28.19
28.14
28.17
28.19
30.04
30.04
30.07
30.06
30.05
29.96
30.05
29.40
No. of Shareholders
27,484
27,425
27,889
28,250
24,257
24,235
24,279
23,910
23,494
22,237
20,519
19,066
Corporate Actions
29 records
Back to all stocks